HGH Fragment 176-191
Also known as: HGH Frag 176-191, Growth hormone fragment 176-191, AOD fragment, Lipolytic fragment of human growth hormone
Research use only — not for sale
Peptides are research compounds; most are not approved for human use and are not dietary supplements or medicines. Availability and legality differ by country. Listing here is a scaffold only. Before any real sale, a legal sign-off plus a licensed / eligibility + age + jurisdiction gate is required.
What it is
A peptide research compound. Listed for catalog reference only. Identity, purity, and any permitted use are subject to the legal review above; no human use is characterized here.
Legality by market
- United States
- Not available in US
- Canada
- Not available in CA
HGH Fragment 176-191 is not an approved drug and is not a legal dietary supplement in the United States; it is sold only as a research chemical and is excluded from the supplement catalog. The related modified fragment AOD-9604 was investigated as a drug but never approved. In Canada it is likewise not an authorized drug or Natural Health Product and is excluded; it cannot be lawfully prescribed or compounded for human use. WADA-prohibited at all times (class S2). Not for human use outside of authorized research.
No NPN; HGH Fragment 176-191 is not an approved Natural Health Product or drug in Canada. It has no Drug Identification Number and no authorized market pathway as a consumer product, and it cannot be lawfully prescribed or compounded for human use.
Status read from XyberHealth’s per-ingredient regulatory data — not invented.
Eligibility + legal review required before purchase
No checkout exists for these items. Enabling any sale would require, at minimum: documented legal sign-off per market, a licensed-purchaser / eligibility check, and an age + jurisdiction gate — none of which is in place today.
Legality & safe sourcing in 🌐 United States
Legal status
Mixed. FDA-approved peptide drugs (semaglutide as Ozempic/Wegovy/Rybelsus, tirzepatide as Mounjaro/Zepbound) are prescription-only and the only fully legal route. Licensed-compounded peptides (503A patient-specific / 503B outsourcing facilities) are legal only for substances on the FDA 503A/503B bulks lists or with a valid clinical-need exception; mass compounding of GLP-1 copies is no longer permitted now that the shortages have ended. BPC-157, TB-500, ipamorelin, CJC-1295, thymosin and most 'wellness' peptides are NOT FDA-approved and are largely unavailable through legitimate compounding; they are sold only as research-use-only chemicals (not for human use).
The only legitimate route
Approved-drug-only for the GLP-1s: obtain branded Ozempic/Wegovy/Zepbound/Mounjaro via a licensed prescriber or a legitimate telehealth platform that prescribes FDA-approved brand product. Compounded peptides only from a state-licensed 503A pharmacy or FDA-registered 503B outsourcing facility against a valid prescription where a documented clinical need/bulks-list eligibility exists. Non-approved peptides (BPC-157 etc.) have no legitimate consumer route for human use.
Switch your region in the header to see another market. We do not link to or endorse any gray-market or “research-chemical” seller — only approved drugs on prescription and licensed pharmacies.
How to verify a peptide is legitimate & lab-tested
- Independent third-party Certificate of Analysis (COA) for the specific batch/lotA batch-specific COA from an outside lab confirms what is actually in the vial. In-house-only testing is a conflict of interest because the seller both profits from and certifies the product. The COA should match the exact lot number on your product.
- Testing lab is ISO/IEC 17025 accredited (verifiable on ANAB or A2LA registries)ISO 17025 accreditation means the lab is independently qualified to produce reliable analytical results. You can cross-check the lab's name on the ANAB (ANSI National Accreditation Board) or A2LA registry, so a named, verifiable accredited lab is far more trustworthy than an unnamed one.
- Identity and purity testing by HPLC plus mass spectrometry, with purity (typically >98%) and correct molecular weight documentedHPLC quantifies purity and the chromatogram reveals impurities; mass spectrometry confirms the molecule is actually the labeled peptide and not a substitute or degraded product. Both together verify identity and quality, not just presence.
- Potency within label tolerance (about +/-10%) and a COA dated recently (e.g., within ~90 days)Confirms the dose is accurate and the data is current rather than a stale or recycled certificate. Out-of-tolerance potency means under- or over-dosing risk.
- USP / cGMP compounding with documented sterility (USP <71>) and endotoxin (USP <85> LAL) testing for any injectableInjectable products must be sterile and endotoxin-controlled to avoid infection and pyrogenic reactions; cGMP and USP-standard testing (sterility, endotoxin, pH, appearance) are the baseline safety controls a legitimate compounder documents.
- Verifiable licensed-pharmacy credentials: state-licensed 503A pharmacy or FDA-registered 503B outsourcing facility (or the local equivalent national-regulator registration)A legitimate compounded product comes only from a properly licensed/registered facility against a valid prescription. 503B facilities operate under full cGMP; in the UK check GPhC registration, in the EU check the national register and the EU common online-pharmacy logo, in Canada provincial licensing and a DIN. Unlicensed sellers cannot legally supply human-use product.
- Batch/lot identity traceability: lot number on the product matches the COA and the pharmacy/manufacturer can trace itLot traceability lets you tie the physical product to its specific test data and enables recalls. If the lot on the vial does not match the COA, the certificate does not actually describe what you received.
- Product is an approved drug (or legitimately prescribed) rather than labeled 'research use only / not for human consumption'RUO labeling is the hallmark of the gray/research-chemical market and signals the product was never made, tested, or authorized for human use. The only legitimate consumer routes are approved drugs dispensed on prescription or pharmacy-compounded products where lawful.
Covers 8 markets: US · CA · UK · EU · AU · NZ · AE · LB. A legitimate product is an approved drug dispensed on prescription, or one compounded by a licensed pharmacy where lawful — with a batch-specific COA from an ISO 17025 lab.